Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide
Author: Horowitz, M.
Visboll, T.
Zdravkovic, M.
Hammer, M.
Madsbad, S.
Citation: Diabetes Obesity & Metabolism, 2008; 10(7):593-596
Publisher: Blackwell Publishing Ltd
Issue Date: 2008
ISSN: 1462-8902
Statement of
M. Horowitz, T. Vilsbøll, M. Zdravkovic, M. Hammer and S. Madsbad
Keywords: Humans; Gastrointestinal Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Middle Aged; Female; Male; Glucagon-Like Peptide 1; Incretins
Rights: Journal Compilation © 2008 Blackwell Publishing Ltd
RMID: 0020080545
DOI: 10.1111/j.1463-1326.2008.00861.x
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.